Effects of Otago and Frenkel's Exercises on Strengthening of Antigravity Muscles in Parkinson's Disease.

November 29, 2025 updated by: University of Lahore
Using both Otago and Frenkel's exercises offers complementary benefits building muscle strength and refining coordination in anti-gravity muscles making daily activities safer and more fluid for people with Parkinson's.

Study Overview

Status

Completed

Conditions

Detailed Description

Combining Otago and Frenkel's exercises can slow functional decline, reduce falls, and improve quality of life for Parkinson's patients. These programs empower patients and families by promoting active participation in care rather than relying only on medications. Early introduction, guided by physiotherapists, gives the best outcomes helping patients stay mobile, confident, and independent for longer.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab Province
      • Gujranwala, Punjab Province, Pakistan, 50250
        • University of Lahore

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patient diagnosed with parkinsons disease using the Hoehn and Yahr scale
  2. Patient age 55-75.
  3. Both male and female.
  4. Able to walk independently.
  5. Willing and ability to provide information consent to participate in study. -

Exclusion Criteria:

  1. Presence of other neurological condition(stroke, multiple sclerosis).
  2. severe cardiovascular disease.
  3. major psychiatric disorder.
  4. currently participating in other study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Otago Exercise Program
20 Participants in this arm will undergo a combined exercise program consisting of the Otago Exercise Program (OEP) and conventional Physiotherapy. The intervention is designed to strengthen antigravity muscles (hip, knee, and trunk extensors), improve balance, coordination, and functional mobility, and reduce fall risk in patients with Parkinson's disease.
After collecting the patient's data appropriate modalities will be applied to initiate the treatment session. This includes the use of an Electric Heating pad on the lower limb for 10 mints. Gentle walking will be performed for 1 mints along with arm swing (10 repetitions) and neck stretching focusing on upper trapezius muscle (3 repetition).After that the12 steps of Otago exercise will be performed with 10 repetition.Total session time is 40 mints.
Experimental: Frenkel's Exercise Program
20 Participants in this arm will under go Frenkel's Exercises program and conventional physiotherapy. This intervention help Parkinsons patient by improving coordination, balance and enhance motor learning and confidence
After collecting the patient's data sessions will be delivered 3 times per week lasting for 40 mints only and than appropriate modalities will be applied to initiate the treatment session. This includes the use of an Electric Heating pad on the lower limb for 10 mints. Gentle walking will be performed for 1 mints along with arm swing (10 repetitions) and neck stretching focusing on upper trapezius muscle (3 repetition).After that the steps of Frenkels exercise program will be performed on patients with 10 repetition.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Antigravity muscle strenght (Manual Muscle strength).
Time Frame: Baseline before treatment (week 0) post -interventiom (week 4 )

Strength of major antigravity muscle including Hip muscles, Knee muscles and ankle muscles.

strength evaluated by using Manual Muscle Testing based on oxford Grading Scale (0-5).

. Grade 0 ( No contraction).

  • Grade 1 (trace): slightly contraction detected but no movement occur at joint.
  • Grade 2 (poor): Full range of motion in a gravity eliminated position.
  • Grade 3(Fair): Full range of motion against gravity.
  • Grade4 (Good): Full range of motion against gravity moderate resistance.
  • Grade5 (Normal) Full Range of motion against gravity and maximum resistance. Participants tested in standardized position for each group. unit of measurement : MMT grade (0-5)
Baseline before treatment (week 0) post -interventiom (week 4 )
Balance and reduction in fall risk.
Time Frame: baseline Before treatment (0 Week) post- intervention ( 4 week )
Balance assessed through the Berg Balance Scale (BBS). Berg Balance Scale items: 14 Tasks (sit to stand, standing, stepping, unsupported, reaching, turning) total score (0-56) scoring:0-4 for each task Maximum score=56 41-56=low Fall risk 21-40=Medium Fall risk 0-20=High Fall risk
baseline Before treatment (0 Week) post- intervention ( 4 week )

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 18, 2025

Primary Completion (Actual)

August 18, 2025

Study Completion (Actual)

August 18, 2025

Study Registration Dates

First Submitted

August 26, 2025

First Submitted That Met QC Criteria

November 29, 2025

First Posted (Actual)

December 11, 2025

Study Record Updates

Last Update Posted (Actual)

December 11, 2025

Last Update Submitted That Met QC Criteria

November 29, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • UOL/IREB/25/09/0051
  • UOL (UOL/IREB/25/09/0051)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson

Clinical Trials on Otago exercises

Subscribe